Yoseph Shaaltiel

2008

In 2008, Yoseph Shaaltiel earned a total compensation of $444.7K as Executive Vice President, Research and Development at Protalix BioTherapeutics, a 61% increase compared to previous year.

Compensation breakdown

Option Awards$163,328
Salary$226,652
Other$54,704
Total$444,684

Shaaltiel received $226.7K in salary, accounting for 51% of the total pay in 2008.

Shaaltiel also received $163.3K in option awards and $54.7K in other compensation.

Rankings

In 2008, Yoseph Shaaltiel's compensation ranked 6,866th out of 9,135 executives tracked by ExecPay. In other words, Shaaltiel earned more than 24.8% of executives.

ClassificationRankingPercentile
All
6,866
out of 9,135
25th
Division
Manufacturing
2,565
out of 3,436
25th
Major group
Chemicals And Allied Products
582
out of 815
29th
Industry group
Drugs
407
out of 597
32nd
Industry
Biological Products, Except Diagnostic Substances
69
out of 118
42nd
Source: SEC filing on September 19, 2011.

Shaaltiel's colleagues

We found four more compensation records of executives who worked with Yoseph Shaaltiel at Protalix BioTherapeutics in 2008.

2008

Iftah Katz

Protalix BioTherapeutics

Vice President of Operations

2008

David Aviezer

Protalix BioTherapeutics

Chief Executive Officer

2008

Yossi Maimon

Protalix BioTherapeutics

Chief Financial Officer

2008

Einat Almon

Protalix BioTherapeutics

Senior Vice President, Product Development

News

You may also like